ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.411,55
-0,27%
S&P 500
5.321,41
0,25%
US Dollar vs BRL
5,1234
0,37%
Bitcoin
70.364,85
-1,53%
Brent Oil
82,445
-1,30%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. OpGen Inc (OPGN)

  7. OpGen Inc (OPGN) Notícias

OPGN

OpGen (OPGN)

OpGen Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:OPGN
DataHoraFonteTítuloCódigoCompanhia
17/05/202418:02Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:OPGNOpGen Inc
16/05/202408:00GlobeNewswire Inc.OpGen Announced 1-for-10 Reverse Stock SplitNASDAQ:OPGNOpGen Inc
14/05/202417:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:OPGNOpGen Inc
29/04/202417:05GlobeNewswire Inc.OpGen Provides Update on Business Operations and Strategic OpportunitiesNASDAQ:OPGNOpGen Inc
23/04/202417:15GlobeNewswire Inc.OpGen Receives Nasdaq Notice Regarding Delayed Form 10-KNASDAQ:OPGNOpGen Inc
26/03/202417:20AllPennyStocks.comShares Rip In Reaction To Activist Investor Becoming CEONASDAQ:OPGNOpGen Inc
25/03/202417:05GlobeNewswire Inc.OpGen Announces Acquisition of Preferred Stock by David LazarNASDAQ:OPGNOpGen Inc
24/11/202302:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:OPGNOpGen Inc
14/11/202318:30GlobeNewswire Inc.OpGen Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
13/11/202318:59Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:OPGNOpGen Inc
13/10/202318:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:OPGNOpGen Inc
13/10/202318:17Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:OPGNOpGen Inc
12/10/202313:32GlobeNewswire Inc.OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross ProceedsNASDAQ:OPGNOpGen Inc
28/09/202317:24Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:OPGNOpGen Inc
14/08/202309:45Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:OPGNOpGen Inc
10/08/202317:15GlobeNewswire Inc.OpGen Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
07/08/202308:30GlobeNewswire Inc.OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud OfferingNASDAQ:OPGNOpGen Inc
03/08/202309:00GlobeNewswire Inc.OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration AgreementNASDAQ:OPGNOpGen Inc
03/08/202308:30GlobeNewswire Inc.OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern TimeNASDAQ:OPGNOpGen Inc
01/08/202310:40Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:OPGNOpGen Inc
21/07/202317:55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:OPGNOpGen Inc
19/07/202308:30GlobeNewswire Inc.OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FINDNASDAQ:OPGNOpGen Inc
14/07/202317:30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:OPGNOpGen Inc
26/06/202317:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:OPGNOpGen Inc
26/06/202308:30GlobeNewswire Inc.OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in EuropeNASDAQ:OPGNOpGen Inc
22/06/202308:30GlobeNewswire Inc.OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 InstrumentsNASDAQ:OPGNOpGen Inc
20/06/202308:30GlobeNewswire Inc.OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 ConferenceNASDAQ:OPGNOpGen Inc
09/06/202317:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OPGNOpGen Inc
22/05/202318:00Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:OPGNOpGen Inc
15/05/202317:15GlobeNewswire Inc.OpGen Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:OPGNOpGen Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:OPGN

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
PDGR3
PDG REALT ON
BOV
HAGA3
HAGA ON
BOV
INBR32
Inter &
BOV
COGN3
COGNA ON
BOV
SGPS3
SPRINGS ON
BOV
LUPA3
LUPATECH ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
AZEV4
AZEVEDO PN
BOV
BHIA3
Grupo Casas Bahia ON
BOV
AMAR3
LOJAS MARISA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
CASH3
Meliuz S.A ON
BOV
GFSA3
GAFISA ON
BOV
HOOT4
HOTEIS OTHON PN
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados